Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxinB1

Citation
Us. Park et al., Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxinB1, GENE, 251(1), 2000, pp. 73-80
Citations number
27
Categorie Soggetti
Molecular Biology & Genetics
Journal title
GENE
ISSN journal
03781119 → ACNP
Volume
251
Issue
1
Year of publication
2000
Pages
73 - 80
Database
ISI
SICI code
0378-1119(20000613)251:1<73:MITPTS>2.0.ZU;2-B
Abstract
Infection with hepadnaviruses and exposure to aflatoxin B1 (AFB1) are consi dered to be major risk factors in the development of hepatocellular carcino ma (HCC) in humans. A high rate of p53 mutations at codon 249 has been repo rted in these tumors. The tree shrew (Tupaia belangeri chinensis) is a usef ul animal model for the development of HCC after human hepatitis B virus (H BV) infection or AFB1 treatment. Therefore, it was of particular interest t o determine whether the p53 gene in tree shrew HCCs associated with HBV inf ection and/or with exposure to AFB1 is affected in the same manner as in hu man HCCs. We determined the tree shrew p53 wild-type nucleotide sequences b y RT-PCR and automatic DNA-sequencing. Tree shrew wild-type p53 sequence sh owed 91.7 and 93.4% homologies with human p53 nucleotide and amino acids se quences, respectively, while it showed 77.2 and 73.7% homologies in mice. O ne HCC and normal liver tissue from AFB1 treated and one HCC from AFB1- and HBV-treated tree shrew showed no change in p53 sequences, while three HCCs from AFB1- and HBV-treated tree shrews showed point mutations in p53 seque nces. One HCC showed point mutations at codon 275, which is on the DNA-bind ing domain of p53 gene, which might be a cause of gain-of-function during t he development of HCC. As a result, our finding indicates that tree shrews exposed to AFB1 and/or HBV had neither codon 249 mutations nor significant levels of other mutations in the p53 gene, as is the case with humans. (C) 2000 Elsevier Science B.V. All rights reserved.